Notes
FDA Adverse Events Reporting System
Reference
FDA. FDA Drug Safety Communication: FDA warns about several safety issues with opioid pain medicines; requires label changes. Internet Document : 22 Mar 2016. Available from: URL: http://www.fda.gov/Drugs/DrugSafety/ucm489676.htm
Rights and permissions
About this article
Cite this article
FDA warning of opioid interaction with serotonergics. Reactions Weekly 1595, 2 (2016). https://doi.org/10.1007/s40278-016-16034-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-016-16034-4